Correlation Between Histogen and Entera Bio
Can any of the company-specific risk be diversified away by investing in both Histogen and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Histogen and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Histogen and Entera Bio, you can compare the effects of market volatilities on Histogen and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Histogen with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Histogen and Entera Bio.
Diversification Opportunities for Histogen and Entera Bio
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Histogen and Entera is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and Histogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Histogen are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of Histogen i.e., Histogen and Entera Bio go up and down completely randomly.
Pair Corralation between Histogen and Entera Bio
Given the investment horizon of 90 days Histogen is expected to generate 1.3 times less return on investment than Entera Bio. But when comparing it to its historical volatility, Histogen is 1.33 times less risky than Entera Bio. It trades about 0.11 of its potential returns per unit of risk. Entera Bio is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 212.00 in Entera Bio on November 1, 2024 and sell it today you would earn a total of 21.00 from holding Entera Bio or generate 9.91% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Histogen vs. Entera Bio
Performance |
Timeline |
Histogen |
Entera Bio |
Histogen and Entera Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Histogen and Entera Bio
The main advantage of trading using opposite Histogen and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Histogen position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.Histogen vs. Virax Biolabs Group | Histogen vs. Artelo Biosciences | Histogen vs. Curis Inc | Histogen vs. SAB Biotherapeutics |
Entera Bio vs. NLS Pharmaceutics AG | Entera Bio vs. Alterity Therapeutics | Entera Bio vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |